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Abstract
Background: Antibiotic-resistant Salmonella enterica serovar Paratyphi A, the agent of paratyphoid A fever, poses an
emerging public health dilemma in endemic areas of Asia and among travelers, as there is no licensed vaccine. Integral to
our efforts to develop a S. Paratyphi A vaccine, we addressed the role of flagella as a potential protective antigen by
comparing cell-associated flagella with exported flagellin subunits expressed by attenuated strains.
Methodology: S. Paratyphi A strain ATCC 9150 was first deleted for the chromosomal guaBA locus, creating CVD 1901.
Further chromosomal deletions in fliD (CVD 1901D) or flgK (CVD 1901K) were then engineered, resulting in the export of
unpolymerized FliC, without impairing its overall expression. The virulence of the resulting isogenic strains was examined
using a novel mouse LD50 model to accommodate the human-host restricted S. Paratyphi A. The immunogenicity of the
attenuated strains was then tested using a mouse intranasal model, followed by intraperitoneal challenge with wildtype
ATCC 9150.
Results: Mucosal (intranasal) immunization of mice with strain CVD 1901 expressing cell-associated flagella conferred
superior protection (vaccine efficacy [VE], 90%) against a lethal intraperitoneal challenge, compared with the flagellin
monomer-exporting mutants CVD 1901K (30% VE) or CVD 1901D (47% VE). The superior protection induced by CVD 1901
with its cell-attached flagella was associated with an increased IgG2a:IgG1 ratio of FliC-specific antibodies with enhanced
opsonophagocytic capacity.
Conclusions: Our results clearly suggest that enhanced anti-FliC antibody-mediated clearance of S. Paratyphi A by
phagocytic cells, induced by vaccines expressing cell-associated rather than exported FliC, might be contributing to the
vaccine-induced protection from S. Paratyphi A challenge in vivo. We speculate that an excess of IgG1 anti-FliC antibodies
induced by the exported FliC may compete with the IgG2a subtype and block binding to specific phagocyte Fc receptors
that are critical for clearing an S. Paratyphi A infection.
Citation: Gat O, Galen JE, Tennant S, Simon R, Blackwelder WC, et al. (2011) Cell-Associated Flagella Enhance the Protection Conferred by Mucosally-Administered
Attenuated Salmonella Paratyphi A Vaccines. PLoS Negl Trop Dis 5(11): e1373. doi:10.1371/journal.pntd.0001373
Editor: Edward T. Ryan, Massachusetts General Hospital, United States of America
Received July 28, 2011; Accepted September 8, 2011; Published November 1, 2011
Copyright:  2011 Gat et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding for this study was from the Middle Atlantic RCE Program NIAID/NIH 2 U54 AI057168 grant (MML, Principal Investigator). RS was also supported
by NIH T32 AI07524 Fellowship Training Program in Vaccinology (MML, Principal Investigator). The funders had no role in study design, data collectiona n d
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jgalen@medicine.umaryland.edu
Introduction
Four human host-restricted Salmonella enterica serovars cause
clinically indistinguishable typhoid (Salmonella Typhi) and paraty-
phoid (S. Paratyphi A, B and [uncommonly] C) fever [1]. Multiply
antibiotic resistant S. Paratyphi A have emerged in Asia,
accompanied by increased incidences of paratyphoid fever in
endemic populations [2,3] and in travelers [4]. Whereas vaccines
exist to prevent typhoid fever, there is no licensed vaccine to
prevent S. Paratyphi A disease. Vaccines for preventing typhoid
fever include the purified Vi capsular polysaccharide administered
parenterally and attenuated Vi-negative strain Ty21a given orally
as a live vaccine [5]. Vi conjugated to recombinant exotoxin A of
Pseudomonas aeruginosa conferred on Vietnamese children a high
level of efficacy in a field trial [6,7]. Vi-based vaccines cannot
protect against paratyphoid disease as S. Paratyphi A does not
express Vi. Oral Ty21a confers moderate cross protection against
S. Paratyphi B [8] but not S. Paratyphi A [9]. Despite the public
health need [4], there have been few reports on modern S.
Paratyphi A vaccine development [10,11].
Attenuated Salmonella strains can be employed as mucosally-
delivered vaccines or as ‘‘reagent strains’’ to achieve safe, high-yield
production of purified antigens for manufacture of parenteral
(conjugate) vaccines. A Salmonella surface antigen that has generated
www.plosntds.org 1 November 2011 | Volume 5 | Issue 11 | e1373renewed interest in the role that it may play in protection is the
flagellum. Flagella mediate intestinal epithelial and macrophage
inflammation following infection and contribute to early host innate
immune responses against Salmonella [12]. Flagellin (FliC), the
monomer of flagellar filaments that induces these effects, is being
incorporated into fusion proteins linked to otherwise poorly
immunogenic antigens and haptens, providing adjuvant activity to
enhance immune responses to those moieties [13–15].
The flagellum is a complex motility organelle composed of .20
different proteins that form a basal body, hook, filament and an
export system. The major extracellular part of the flagellum
comprises ,20,000 FliC monomers that are exported and
assembled at the terminus of a growing filament. Between the
hook and filament is a short junction formed by two hook-
associated proteins, FlgK and FlgL [16,17]. S. Typhimurium
mutants defective in FlgK or FlgL synthesize FliC monomers that
do not polymerize and are released into the culture medium [17].
A capping structure of five FliD molecules at the end of the
filament also promotes FliC polymerization [16,18,19]. Deletion
of fliD in S. Typhimurium incapacitates the ability of transported
FliC to polymerize [20,21].
Integral to our efforts to develop a S. Paratyphi A vaccine, we
addressed the role of flagella as a potential protective antigen by
comparing cell-associated flagella with exported flagellin subunits
expressed by attenuated strains. Mutants were constructed with
deletions in fliD or flgK, resulting in export of unpolymerized FliC,
without impairing its overall expression. These strains allowed us
to investigate whether expression of FliC as cell-attached flagellin
filaments versus exported monomers, would influence the immune
response or protection elicited by these live vaccines.
Materials and Methods
Ethics statement
All animal experiments carried out in this work were approved
by the University of Maryland Baltimore Office of Animal Welfare
Assurance (OAWA), under approved Animal Use Protocol
0409006.
Bacterial strains, media and growth conditions
S. Paratyphi A wild-type and mutant strains (Table 1) were
propagated on animal product-free LB Lennox medium (Athena
ES, Baltimore, MD). Lennox agar plates were prepared by addition
of 1.5% agar (Difco, BD, Franklin Lakes, NJ). Guanine (0.001% v/
v) was added for DguaBA mutant strains. Liquid cultures were
incubated at 37uC, 250 rpm, at a ratio of 1:10–1:20 vol:vol
medium:flask (high-aeration conditions). For low-aeration growth
conditions, the flasks were filled to 75% of their volume with the
medium, and shaken at 80 rpm. Time course experiments in liquid
culture were seeded with an overnight culture, inoculated to 0.01
OD600; samples were removed at regular intervals for determining
culture turbidity at OD600 or plating. For each growth experiment,
two flasks were cultured per strain, and each experiment was
performed twice. Swimming and swarming assays were carried out
on fresh Lennox plates containing 0.3% and 0.5–0.7% agar,
respectively. Glucose was added to a final concentration of 0.5% for
swarm plates. The swim plates were inoculated by stabbing the
center with bacteria harvested from 1.5% Lennox plates. The
swarm plates were inoculated by pipetting a 10-ml fresh culture,
grown inliquid Lennox mediato 0.5–0.6OD600, onto thesurfaceof
the center of the agar plate. All motility experiments were
performed in triplicates and repeated at least twice. Swim and
swarm abilityareexpressedas the radiusof the mobility zone;forno
swim, the radius of growth was .1 mm and for no swam, 10 mm.
Mutagenesis
Deletion of fliD and flgK genes was performed by l Red-
mediated mutagenesis [22] essentially as described [23]. Primers
(listed in Table 2) were designed to replace most of the gene of
interest with a kanamycin resistance cassette flanked by the
Flippase Recombination Targets, FRTs. The kanamycin cassette
was later deleted via l Red recombinase, leaving an FRT scar
sequence.
SDS-PAGE and western blot analyses
Bacterial protein samples were normalized as follows. Cell
pellets were washed in 0.125 M Tris-HCl, pH 6.8, brought to 10
Table 1. Salmonella Paratyphi A strains and their relevant
characteristics.
Strain description Source
ATCC 9150 WT CVD-Baltimore collection
Q28b Clinical isolate CVD-Baltimore collection,
isolated in Mali
EAR 6473 Clinical isolate CVD-Baltimore collection,
isolated in Chile
15.067 Clinical isolate CVD-Baltimore collection,
isolated in Chile
CVD 1901 ATCC 9150 DguaBA Levine MM, unpublished
CVD 1902 CVD 1901 DclpX Levine MM, unpublished
9150D ATCC 9150 DfliD This study
9150K ATCC 9150 DflgK This study
CVD1901D CVD 1901 DfliD This study
CVD1901K CVD 1901 DflgK This study
doi:10.1371/journal.pntd.0001373.t001
Author Summary
Salmonella enterica serovar Paratyphi A is a pathogen that
causes a systemic disease that is marked by serious
complications and, if untreated, high mortality. The study
of S. Paratyphi A pathogenesis and vaccine development
has been extremely challenging since S. Paratyphi A is
human host-restricted and no appropriate animal model
exists. Since there is currently no licensed vaccine to
prevent paratyphoid fever caused by this organism, our
study represents a pioneering attempt to develop and
refine a vaccine against S. Paratyphi A. We employed live
attenuated strains which allow in vivo presentation of
bacterial antigens via the natural route of infection,
without the complications associated with antigen pro-
duction and purification for subunit vaccines. For deter-
mining protective immunity against infection, we devel-
oped a mouse model that allowed evaluation of vaccine
efficacy. We used our system to examine the protective
capacity of a major Salmonella antigen, the flagellum. Due
to its unique immunogenic properties, the flagellum is
considered a major immune mediator, but its role in
protection is controversial. We clearly show that cell-
associated flagellar protein, presented by mucosally
administered attenuated bacterial live vaccines, provides
superior protection when compared to strains exporting
FliC monomers, and we discuss possible mechanisms of
immunity.
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buffer (Bio-Rad Laboratories, Hercules, CA). Supernatants were
brought to the equivalent lowest OD600 culture per experiment, by
addition of 0.125 M Tris-HCl, pH 6.8, and diluted 1:1 with
Laemmli buffer. The protein samples were boiled for 10 min, and
10-ml aliquots were loaded onto 10% SDS-PAGE gels. For anti-
FliC blots, monoclonal antibodies (BioVeris, Gaithersburg, MD)
diluted 1:1000 were used for 1 h incubation. Detection was
performed with secondary peroxidase-labeled goat anti-mouse IgG
(KPL, Gaithersburg, MD), followed by application of the ECL
PLUS Western blotting detection system (GE Healthcare,
Buckinghamshire, UK). Coomassie blue-stained gels and devel-
oped blots were scanned with a V700 Photo EPSON Scan (digital
ICE technologies) using SilverFast SE imaging software (LaserSoft
Imaging, Sarasota, FL), and quantitated with QuantityOne
software (Bio-Rad).
Preparation of S. Paratyphi A flagella protein standard
S. Paratyphi A FliC was prepared from strain CVD 1902 using
the shearing. CVD 1902 was chosen for purification of flagella for
two reasons. First, it was genetically engineered from the
attenuated strain CVD 1901 to hyper-express flagellin by deletion
of the clpX gene (Table 1), which together with clpP encodes the
ClpXP ATP-dependent protease that degrades the master flagella
positive regulator complex FlhD/FlhC, resulting in large amounts
of flagella being over-produced [24]. Second, it is an attenuated
strain and as such does not pose an occupational risk when
cultured in large volumes for antigen purification.
Bacterial cultures were grown overnight under low aeration
conditions in 2-liter flasks containing Lennox broth supplemented
with guanine. Cell pellets were washed and resuspended in PBS,
and sheared for 3 min at high speed in a Waring laboratory
blender. The sheared suspension was centrifuged twice at 7,0006g
for 10 min, and the supernatant was collected and centrifuged at
100,0006g for 3 h to pellet the filaments. The pellet was
suspended in saline at 4uC overnight, centrifuged at 7,0006g,
and the clear supernatant containing flagellar filaments was
transferred to a new tube. Protein concentration was determined
with the BCA assay (Pierce, Rockford, IL). Purity was assessed by
SDS-PAGE and Coomassie blue staining. The amount of
contaminating LPS was quantified using the resorcinol sulfuric
acid assay [25] using a standard curve generated with purified S.
Paratyphi A LPS. This FliC preparation was determined to be
98.3% pure.
Ultrafiltration
UF membranes with different Mr cut-offs were used for gradient
separation of flagellin monomers from purified filaments. Super-
natants collected from bacterial cultures grown under high-
aeration conditions and containing flagellin monomers and/or
sheared flagella, were first normalized to equal concentrations of
FliC by passing supernatants through a 30-kDa cut-off Amicon
membrane (Millipore, Billerica, MA). The concentrated retentants
were then passed through a 100-kDa cut-off Amicon membrane.
The resulting filtrates were further passed through an additional
30-kDa membrane.
Transmission electron microscopy
Bacteria collected from swarm colonies were suspended in PBS
to an OD600 of 1.0 and were incubated with 300 mesh Formvar
coated copper grids (Electron Microscopy Services, Hatfield, PA)
for 20 min. Grids were gently blotted and placed on 50 ml drops of
2% ammonium molybdate (Sigma Aldrich, St. Louis, MO) for
2 min. After air-drying, grids were observed with a JEOL electron
microscope JEM-1200EX (JEOL, Toyko, Japan).
Mice housing and handling
For all experiments, 6 week-old female BALB/c mice were
purchased from Charles River Breeding Laboratory Inc. (Wil-
mington, MA) and maintained in a biohazard animal facility.
Anesthesia (isofluorane dispensed through a precision vaporizer)
was used for blood collection from the retro-orbital plexus. All
studies were approved by the Institutional Animal Care and Use
Committee (IACUC) of the University of Maryland Baltimore
School of Medicine, and conducted in accordance with NIH
guidelines [23].
Mice LD50
For assessment of virulence, the hog gastric mucin assay was
used [26]. Mice were injected by the intraperitoneal route (i.p.)
with increasing 10-fold dilutions of bacteria; bacteria were
harvested from overnight Lennox plates and suspended in PBS
mixed with 10% (wt/v) Difco hog gastric mucin (Becton-
Dickinson, Sparks, MD) to a final volume of 0.5 ml per mouse.
Table 2. Mutagenesis oligonucleotides sequence.
Designation Use* Sequence (59 to 39)**
PCR1-5FRT-aph Km
R cassette gaattcgctagcGCTGGAGCTGCTTCGAAGTTC
PCR1-3FRT-aph Km
R cassette ctcgagTTCCGGGGATCCGTCGACCTGCAGTTC
PCR2-5FliD fliD deletion gaattcTCACGCACACGCTGCAGG
PCR2-5FliD-rev fliD deletion gctagcACCTAATGATGAAATTGAAGCCATGC
PCR3-3FliD fliD deletion gaattcGCTATGAACAAGTCCTGATAACAGAGGT
PCR3-3FliD-rev fliD deletion ctcgagTTAACGAGAACTCCTGGAAAGATGCTTTC
GGTGAAATCTGC
PCR4-5FlgJ flgK deletion gaattcGGCGAACCCAGCTATAACGTATTTGGCG
PCR4-3FlgJ flgK deletion gctagcATTAATCAAGCTGGACATGATGGTTCC
PCR5-5FlgL flgK deletion agatctGCGTTACTGAATATTCGCTAAAGGAGAAG
PCR5-3FlgL flgK deletion ctcgagCGTATGGCCAATTACCATCGTGCGTGCG
*Km
R, Kanamycin resistance gene.
**Restriction endonuclease cleavage sites are underlined. For PCR1, EcoRI, NheI and XhoI; PCR2 and PCR 4, EcoRI and NheI; PCR3, BamHI and XhoI; PCR5, BglII and XhoI.
doi:10.1371/journal.pntd.0001373.t002
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observed twice daily for 3 days for mortality or any signs of
significant morbidity (ruffled fur, weight loss of 20% or more,
collapse, difficulty breathing or severe dehydration), and those
showing the above signs were euthanized according to IACUC
directives. 72 h post-challenge, surviving mice were euthanized
using CO2 asphyxiation followed by cervical dislocation. LD50
values were calculated by logistic regression analysis.
Mucosal immunization and challenge
Fresh vegetative cultures of CVD 1901, CVD 1901D or CVD
1901K were pelleted, washed with PBS, and brought to a final
concentration of ,10
11 cfu/ml. 10-ml aliquots were applied
intranasally on day 0, 14, and 28 to mice (5 ml/nostril, ,10
9 cfu
per mouse; 10–15 mice per group). A group immunized with PBS
served as a negative control. Blood samples were collected prior to
and after immunization and sera were stored at 270uC. Mice
were challenged on day 56 with 3.3610
5 cfu per mouse of wild-
type ATCC 9150 S. Paratyphi A, freshly prepared as described
above for the LD50 studies. Iron (8 ml of 5% ammonium iron (III)
citrate to 1 ml of mucin) was added to the bacterial suspension to
increase virulence [27]. Following the challenge, mice were
monitored every 6 h for 72 h for mortality or any signs of
significant morbidity.
ELISA
Total IgG antibodies and IgG subclasses against S. Paratyphi A
flagella were determined by ELISA as previously described [28].
Briefly, 96-well plates were coated with S. Paratyphi A flagella
(5 mg/well) or LPS (10 mg/ml). Samples were diluted in 10% dried
milk in PBS containing 0.05% Tween 20 (PBSTM) and tested in
duplicates. Specific antibodies were detected using HRP-labeled
goat anti-mouse IgG, IgG1 and IgG2 (KPL Inc. Gaithersburg,
MD) diluted in PBSTM followed by TMB Microwell Peroxidase
Substrate solution (KPL). Titers were calculated by interpolation
in a standard curve as the inverse of the dilution that produces an
OD value of 0.2 above the blank (ELISA units/ml).
Bactericidal assay
Bactericidal activity was assessed by a complement-mediated
lysis of S. Paratyphi A using sera from immunized mice. Fresh
vegetative wild-type ATCC 9150 (flagellated) or 9150K (non-
flagellated) bacterial suspensions (10
6 cfu/ml) were mixed with
30% guinea pig complement (Sigma-Aldrich, St. Louis, MO),
added (1:1) to heat-inactivated (56uC, 20 min) serially-diluted
mouse sera, and incubated for 1 h at 37uC. Following incubation,
bacteria were counted by plating. End point titers were defined as
the last dilution that induced a $50% reduction in the number of
bacteria incubated with complement alone without addition of
serum.
Opsonophagocytosis
Antibody-mediated bacterial uptake by macrophages was
measured by seeding J774A.1 cells into 24-well microdilution
plates and growing in DMEM supplemented with 5% FCS at
37uC with 5% CO2 to a confluent layer (2610
5 cells/well). Fresh
vegetative wild-type ATCC 9150 bacteria were incubated with
heat inactivated mouse serum (10% in PBS) for 30 min on ice,
then added to the cell monolayer at a ratio of 1:1. Following
centrifugation (1006g, 10 min), the microdilution plate containing
the monolayer and opsonized bacteria was incubated at 37uC with
5% CO2 for 30–45 min. External bacteria were removed by
replacing the media with fresh media containing 100 mg/ml
gentamicin, incubating for 30–45 min, followed by three PBS
washes. The cells were lysed with 0.5% Triton x-100 and
internalized bacteria were counted by plating.
Statistical analysis
LD50 was estimated by logistic regression analysis. Continuous
variables were compared among the groups using Kruskal-Wallis
analysis of variance. Proportions in two groups were compared
using the Fisher’s exact test. Two-sided p-values,0.05 and one-
sided p-values,0.025 were considered statistically significant.
Results
Selection of a parental S. Paratyphi A strain for
developing attenuated vaccines
Four S. Paratyphi A wild-type strains were compared for growth
rate, bacterial cell yield and ability to express FliC, including
American Type Culture Collection strain ATCC 9150 and three
clinical isolates Q82b (Mali), EAR6473 (Chile) and 15.067 (Chile).
No significant differences in growth rate (Fig. 1A) or overall
protein electrophoretic profiles (Fig. 1C) were observed among the
strains, but ATCC 9150 consistently reached the highest cell yield
when grown in rich liquid medium (Fig. 1B). FliC was a major
component of the secretomes of all four strains (Fig. 1C, middle
panel). The high amounts of flagellar protein found in the
supernatants are a consequence of shear forces acting upon the
cells during growth in shake flasks, causing filament shearing from
the cell surface. Among the four strains, the Chilean isolate 15.067
expressed lower levels of FliC (Fig. 1C, lower panel).
To compare flagellar protein expression further, ‘‘swim’’ and
‘‘swarm’’ motilities were tested, each providing evidence of flagella
functionality [29]. Swimming is assayed by growing the bacteria
on semisolid medium (0.2–0.4% agar) where bacterial cells swim
through water-filled channels in the agar, whereas swarming is
observed following inoculation on the surface of solid medium
(0.5–0.8% agar). Notably, swarming is associated with greater
flagella expression than swimming [29]. In accordance with FliC
expression (Fig. 1C), strain 15.067 had reduced motility (Fig. 1D).
We next tested whether variations of flagellar expression affect
virulence in mice. Since S. Paratyphi A is avirulent in mice when
administered orally or intranasally (i.n.), we adopted a mouse
model used for S. Typhi (another human host-restricted pathogen)
to determine LD50, in which bacteria are suspended in hog gastric
mucin prior to intraperitoneal (i.p.) injection of BALB/c mice.
This model has been used to assess the attenuation of candidate
oral S. Typhi vaccines pre-clinically [26,30] and reasonably
predicted responses of humans given those strains in Phase 1 trials
[31,32]. Accordingly, young mice were injected i.p. with 10-fold
dilutions of bacteria in 10% (w:v) hog gastric mucin. ATCC 9150
was the most virulent, with an LD50 value of 52 cfu/mouse, while
strains Q82b, EAR6473 and 15.067 exhibited LD50 values of 846,
199 and 692 cfu/mouse, respectively (Fig. 1E). ATCC 9150, with
its excellent growth characteristics, copious flagella production and
high virulence in mice, was therefore selected as the wild-type
parent for construction of our vaccine candidates; the available
genomic sequence of ATCC 9150 provided another rationale for
using this strain [33].
Deletion of fliD or flgK allows flagellin export
To export flagellin as monomers, we targeted two chromosomal
loci, FliD (flagellar cap protein) and FlgK (a hook-filament
junction protein), shown in S. Typhimurium to encode hook-
associated proteins [17,20,34]. To assure the safety of our
candidate strains, we first introduced a deletion in the chromo-
S. Paratyphi A Surface Flagella Enhance Protection
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enzymes, inosine monophosphate dehydrogenase (GuaB) and
guanine monphosphate synthetase (GuaA), involved in the de novo
guanine nucleotide biosynthesis pathway. Resulting strain CVD
1901 was then further deleted for fliD (yielding CVD 1901D)o r
flgK (CVD 1901K). The fliD or flgK deletions were also introduced
into ATCC 9150, leading to 9150D and 9150K.
ATCC 9150 and the resulting five isogenic strains possessed
indistinguishable growth rates when cultured under high
aeration in appropriately supplemented rich liquid medium
(data not shown). Thus, neither the guaBA, fliD or flgK mutations
impaired growth, although bacterial cell yields were somewhat
lower compared to ATCC 9150 (Fig. 2A top panel). As expected,
analysis of secreted protein confirmed that higher FliC levels
were found in supernatants of the DfliD and DflgK mutants
compared to supernatants from their parental strains (Fig. 2A
lower panel).
Differences in FliC expression between the fliD and flgK
mutants and their parents were pronounced when bacteria were
propagated as stationary broth cultures (low-aeration) where
shear forces acting upon the cells are much lower. Under these
conditions, no free FliC was observed in supernatants of either
parental strain, yet FliC levels in supernatants of the fliD and flgK
mutant cultures were as high as when grown under aerated
conditions (shown for CVD 1901 and derived mutants, Fig. 2B).
Immunoblotting with anti-FliC under low-aeration growth
showed that the parental strain retained most flagella on the
bacterial cells. In contrast, the mutants exhibited almost
undetectable levels of FliC on the cell surface; CVD 1901D
showed some residual FliC, while none was detected on the
surface of CVD 1901K (Fig. 2C).
fliD and flgK deletion mutants differ in export of flagellin
monomers
Export of FliC from the mutants was elucidated by a three-step
characterization (Fig. 3A schema), using serial ultrafiltration (UF)
membranes. First, conditioned media of CVD 1901, CVD 1901D
and CVD 1901K cultures were adjusted to equivalent FliC
concentrations using 30-kDa cutoff UF (Fig. 3A upper gel). Then,
100-kDa (Fig. 3A middle gel) followed by 30-kDa cutoff
membranes allowed separation of monomeric from polymeric
flagellin. Following the final 30-kDa passage, CVD 1901K
supernatant contained the highest amount of flagellin, with less
in the CVD 1901D supernatant and almost none in concentrate of
the parental CVD 1901 strain (Fig. 3A lower). Thus, flagellin
molecules in supernatants from cultures of the fliD and flgK
mutants are in the unassembled form. However, in accordance
with the results shown in Fig. 2C, some flagellin expressed by the
CVD 1901D mutant is cell-associated, sheared off the cell surface
during growth, and retained within the 100-kDa filter. As a
control, all culture supernatants were heat-treated to dissociate the
polymeric flagella and indeed some FliC was observed in the
filtrate of the parental CVD 1901 strain following the 100-kDa UF
(Fig. 3A middle and lower).
Second, comparing flagella functionality revealed identical swim
and swarm diameters (% of plate) for ATCC 9150 versus CVD
1901; 39% versus 43% for swim and 45% versus 69% for swarm,
respectively (Fig. 3B). Strains 9150D and CVD 1901D showed
only swimming motility with a diameter of 11% and no swarming,
while 9150K and CVD 1901K showed neither swim nor swarm
motility. Decreasing the agar concentration in the swarming plates
allowed swarming of the DfliD mutants, while the DflgK mutants
remained non-motile (Fig. 3B). Finally, bacterial samples from the
Figure 1. ATCC 9150 is highly culturable, expresses flagella moderately, and is highly virulent. (A) Growth curves of four S. Paratyphi A
isolates cultured on Lennox medium at 37uC under high aeration (250 rpm, 1:10 medium:flask volume). (B) Final cell yields were recorded at time
point of 8 h (t=8) by performing live counts. Average yields from two independent experiments are shown. (C) Equivalent cell pellets and
supernatants from t=8 were analysed by SDS-PAGE and stained with Coomassie (upper panels) or subjected to Western blot analysis with anti-FliC
antibody (middle), along with S. Paratyphi A FliC standard (100 mg). Estimation of FliC quantity was performed on the blots with Bio-Rad QuantityOne
(lower). (D) Swim (0.3% agar) and swarm (0.7%) plates, following 8 h incubation at 37uC. (E) BALB/c mice were injected i.p. with 4 S. Paratyphi A
isolates. Bacteria were collected from Lennox plates incubated at 37uC over-night, diluted in PBS, and mixed with hog gastric mucin. Groups of naı ¨ve
BALB/c mice, 6 mice per group were challenged and monitored twice daily for three days. Data represent percent cumulative survival curves.
doi:10.1371/journal.pntd.0001373.g001
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The negative stained bacterial cell images establish that the DflgK
mutant is completely devoid of surface flagella, while the DfliD
mutant carries one or two filaments (Fig. 3C).
DfliD and DflgK mutants exhibit similar virulence to their
parental strains
Virulence of the mutants was compared to wild-type ATCC
9150 by inoculating 6 week-old mice i.p. with bacteria suspended
in hog gastric mucin. An LD50 value of 8.8 bacteria per mouse was
calculated for the wild-type (Fig. 4). In contrast, CVD 1901
showed an LD50 of 3.0610
7 cfu/mouse. The LD50s for 9150D,
9150K, CVD 1901D and CVD 1901K were 17, 49, 3.4610
6 and
2.0610
7 cfu/mouse, respectively (Fig. 4). These results show clear
attenuation only for strains harboring the guaBA deletion. Deletion
of either fliD or flgK from ATCC 9150 attenuated the resulting
strain by only half a log and did not work synergistically with the
guaBA deletion. Whereas deletion of flgK or fliD in S. Paratyphi A
did not alter bacterial virulence in this model, these mutations may
nevertheless influence the protection conferred by vaccine strains
also deleted in guaBA. Accordingly, we examined the ability of
these mutants to protect against a S. Paratyphi A lethal challenge.
A live attenuated strain provides superior protection if it
has attached flagella rather than exporting flagellin
monomers
Mice were immunized i.n. with ,1610
9 cfu of CVD 1901,
CVD 1901D or CVD 1901K on days 0, 14 and 28. Control mice
received PBS. The i.n. route was chosen based on the robust
immunity [35,36] and protection [37] induced by attenuated S.
Typhi administered by this route. Three weeks after the last
immunization, mice were challenged with a lethal dose of wild-
type ATCC 9150 (3.3610
5 cfu/mouse plus iron, see Materials
and Methods). All control mice succumbed within 24 hours post-
challenge (Table 3). The vaccine strains differed in their protective
capacity, with CVD 1901 conferring significantly superior
protection compared to CVD 1901D or 1901K.
Serum IgG antibodies against FliC and LPS rose progressively
after each immunization (Fig. 5A), reaching similar levels for all
strains. Unlike CVD 1901 (which expresses many) and CVD
1901D (expresses a few) surface-associated flagella, CVD 1901K is
devoid of flagella at the time of administration. Hence, FliC
antibodies induced by CVD 1901K represent responses to de novo
FliC synthesized in vivo, rather than antigen present at the time of
immunization. The slightly higher titers detected in the mice
immunized with CVD 1901D may reflect the combined effect of
surface-associated and secreted FliC. Overall, there was no
significant correlation between anti-FliC or anti-LPS antibody
titers and survival (Fig. 5B), nor a correlation of survival with
antibodies to S. Paratyphi A outer membrane protein fractions
(data not shown). Thus, no serum IgG responses against major
Salmonella surface antigens correlated with protection in this model.
CVD 1901, CVD 1901D and CVD 1901K induce similar
levels of anti-FliC IgG2a, whereas the flagellin-exporting
mutants induce higher levels of anti-FliC IgG1
Since the overall level of anti-FliC IgG among the immunized
groups did not correlate with efficacy, we examined IgG antibody
subtypes. While all three vaccine strains induced similar levels of
anti-FliC IgG2a antibody, CVD 1901D and CVD 1901K induced
strikingly high levels of anti-FliC IgG1, which were 50- and 10-fold
higher than those induced by CVD 1901, respectively (Fig. 6A,
p=0.012). The IgG2a:IgG1 geometric mean ratios were 1.2,
0.036, and 0.051 for CVD 1901, CVD 1901D, and CVD 1901K
respectively, implying that a functional IgG2a-biased response,
rather than elevated (and likely competing) IgG1 antibodies, might
correlate with enhanced protection (Fig. 6B; p=0.042).
Cell-associated flagella of CVD 1901 elicit antibodies with
opsonophagocytic rather than complement-mediated
bactericidal activity
Noting the differences in anti-FliC IgG subtype antibody
responses induced by the different live vaccines, we next studied
functional activity of the antibodies. Antibody switching to
different IgG subclasses requires T-cell help (TH) during antigen
priming; the presence of IgG1 reflects TH2 subset activity, whereas
IgG2a indicates a TH1-type response. Since live vaccine carrying
cell-associated FliC exhibited higher potency compared with
flagellin-secreting strains, we further examined the potential
contribution of the TH1-associated antibody response induced
by these strains in protection against S. Paratyphi A challenge. The
TH1 subset is responsible for many cell-mediated functions and
favors the production of IgG2a antibodies with opsonophagocytic
capacity that bind to high-affinity Fc receptors on macrophages
[38]. These antibodies activate the complement system more
readily than IgG1 antibodies [39] and efficiently mediate
antibody-dependent cell-mediated cytotoxicity [40].
Complement-mediated antibody killing (bactericidal) of wild-
type ATCC 9150 was assessed by incubating bacteria with serial
dilutions of heat-inactivated sera from immunized mice to which
guinea pig complement was added. Sera from naı ¨ve mice
Figure 2. S. Paratyphi A DfliD and DflgK mutants shade FliC to
culture supernatant. ATCC 9150 and five derivative mutants were
grown on Lennox medium under high aeration. (A) Cell yields (upper
panel) and Coomassie-stained SDS-PAGE (lower) of culture superna-
tants following 8 h of growth. (B) Cell yields and SDS-PAGE of
supernatants from cultures grown over-night under low-aeration. (C)
SDS-PAGE (upper), anti-FliC western blot (middle) and FliC quantita-
tion (lower) of cell pellets from cultures grown over-night under low-
aeration.
doi:10.1371/journal.pntd.0001373.g002
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analogous bactericidal titers against ATCC 9150 were detected
with no significant differences between the groups (Fig. 7A,
p=0.28). Similar results were obtained when the assay was
repeated with the non-flagellated 9150K strain (Fig. 7A, p=0.22),
indicating that anti-FliC antibodies do not play a major role of S.
Paratyphi A complement-mediated killing in this mouse model.
We next examined opsonophagocytic activity using a macro-
phage culture assay that probes the ability of the sera to facilitate
uptake of ATCC 9150. Average numbers of intracellular bacteria
Figure 3. DfliD and DflgK mutants differ in their ability to export non-assembled flagellin. (A) Separation between monomeric and
filamentous FliC using serial UF membranes. Supernatants were brought to equivalent FliC concentration using 30-kDa Amicon UF units and
compared by a Coomassie-stained SDS-PAGE (upper gel). The concentrated samples, with or without heat treatment (70uC, 30 min), were then run
through 100-kDa units and compared again (middle). Filtrates from the previous step were passed through 30-kDa units, and the final concentrates
were detected (lower). (B) Swim (0.3% agar) and swarm (0.7, 0.6 and 0.5%) plates were scanned following 8 h incubation, 37uC. (C) EM images of
negatively-stained bacteria, collected from swarm plates. For CVD1901D, cells carrying two and a single filament are shown. Numbers indicate the
extent of magnification.
doi:10.1371/journal.pntd.0001373.g003
Figure 4. DfliD and DflgK mutations do not impair virulence of S.
Paratyphi A in mice. Survival of naı ¨ve BALB/c mice infected with
different strains of S. Paratyphi A at the indicated doses (cfu/mouse).
Bacteria were collected from plates, diluted in PBS and mixed with hog
gastric mucin. Groups of 6 mice were injected i.p. and monitored twice
daily.
doi:10.1371/journal.pntd.0001373.g004
Table 3. Recorded deaths within immunized mice challenge
with a lethal dose* of S. Paratyphi A ATCC 9150 wild-type
strain.
immunization Mortality Vaccine efficacy p value***
PBS 8/8 - -
CVD 1901 1/10
a 90% 0.0002
1901D 8/15
b 47% 0.026
1901K 7/10
c 30% 0.15
Naı ¨ve** 0/5 - -
*Challenge dose for 52–54 week old mice was 3.3610
5 cfu, 0.125 mMF e
+2 in
10% hog gastric mucin.
**Challenged with mucin but no bacteria.
***Compared to PBS, from one-sided Fisher’s exact test.
avs
b, p=0.034 and
avs
c, p=0.010, one-sided Fisher’s exact test.
doi:10.1371/journal.pntd.0001373.t003
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6 bacteria per well were
recovered for sera from mice immunized with CVD 1901, CVD
1901D, and CVD 1901K, respectively (Fig. 7B), indicating a clear
increased uptake for CVD 1901 sera (p=0.0002). These data
suggest enhanced anti-FliC antibody-mediated clearance of the
organism by phagocytic cells induced by vaccines expressing cell-
associated rather than exported FliC, which might be contributing
to the vaccine-induced survival from S. Paratyphi A challenge in
vivo.
Discussion
Flagellar protein is highly immunogenic and immunomodula-
tory via stimulation of TLR5, yet questions remain over its role in
mediating protection against Salmonella [41–45]. Whereas purified
Phase 1 flagella filaments or FliC subunits from S. Typhimurium
[46] or S. Paratyphi A [10] inoculated parenterally protect mice
against parenteral challenge with wild-type Salmonella of the
homologous serovar, equipoise exists over whether flagellar
protein contributes to protection when presented by live mucosal
or parenteral inactivated whole cell vaccines. Flagellin expression
is not needed for live oral S. Typhimurium vaccines to protect
against wild-type challenge [47], while human studies indicate an
important role for cell-associated flagella in the protection
conferred by parenteral inactivated whole cell typhoid vaccines.
Inactivated whole cell vaccines (most derived from wild-type strain
Ty2) that provided superior protection also elicited higher anti-
flagellar antibodies [48,49]. Importantly, no efficacy was observed
in a large-scale controlled field trial when the inactivated vaccine
was based on non-flagellated S. Typhi mutant TNM1, derived
from strain Ty2 [50], suggesting that inactivated whole cell
vaccines must express flagella in order to protect humans [50].
We employed attenuated S. Paratyphi A to investigate the
protective capacity of the flagellar subunit protein FliC expressed
by live mucosal vaccines. Since mucosally-administered live
vaccines assure in vivo expression and presentation of flagellar
antigens in a native form, we engineered S. Paratyphi A ATCC
9150 with specific deletions affecting flagella filament biosynthesis.
SDS-PAGE and western blotting (Fig. 2A–C), UF fractionation
Figure 5. Serum IgG against S. Paratyphi A FliC and LPS do not correlate with protection. (A) Total serum anti-FliC and anti-LPS ELISA
antibody titers (geometric means 6 standard error of the mean) from days 22 (prior to vaccination), 27 (two weeks following first boost) and 42 (two
weeks following second boost). S. Paratyphi A FliC was extracted from strain CVD 1902. LPS was extracted from strain CVD 1901. (B) Comparison of
anti-FliC and anti-LPS total serum IgG titers at day 42 from individual mice. Closed shapes represent mice that succumbed to the challenge.
doi:10.1371/journal.pntd.0001373.g005
Figure 6. Immunization with CVD 1901D and CVD 1901K but
not CVD 1901, induces high anti-FliC IgG1. Subclass distribution
of IgG antibodies against S. Paratyphi A flagella. (A) Anti-FliC IgG1 and
IgG2a titers detected in day 42 sera. (B) The ratio between the antibody
subclasses. For (A)a n d( B), closed shapes represent mice that
succumbed to the challenge.
doi:10.1371/journal.pntd.0001373.g006
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phenotypes of these FliC-exporting mutants. While ATCC 9150
and CVD 1901 almost exclusively produce flagellar protein as
polymer filaments, 9150D and CVD 1901D (lacking flagellum cap
protein) express only one or two filaments. In contrast, 9150K and
CVD 1901K (lacking a flagellar hook-associated protein) are
completely devoid of flagella. Studies with S. Typhimurium
explain why fliD mutants carry a few intact flagellum polymers.
In DfliD S. Typhimurium mutants [17], the tips of the hooks are
intact and serve as effective heteronuclei for soluble FliC units to
re-associate and form a functional flagellum. A filament already
initiated has higher affinity for the newly added monomers, which
elongate the single filament rather than form more short filaments.
Our engineered strains mutated in fliD or flgK but unaltered in
growth characteristics or virulence (Fig. 4) provided a uniform
background to explore the contribution of flagellar protein to
immunity and protection. Mucosal immunization of mice with the
live vaccines followed by subsequent i.p. challenge with virulent S.
Paratyphi A showed prominent differences in the level of
protection conferred in the face of a potent challenge that killed
100% of control mice (Table 3). CVD 1901 carrying many intact
cell-attached flagella conferred 90% vaccine efficacy (p=0.0002),
while CVD 1901D with just a few cell-attached flagella provided
47% efficacy (p=0.026); CVD 1901K with no attached flagella
elicited only 30% efficacy (p=0.15). Mortality was significantly
lower in CVD 1901 recipients (1/10 mice) than in mice
immunized with CVD 1901K (7/10 mice, p=0.01) or CVD
1901D (8/15 mice, p=0.04). These data indicate an advantage for
live mucosal Salmonella vaccines having cell-attached FliC fila-
ments.
The serum anti-FliC IgG titer did not correlate with
protection. In fact, the less protective live vaccines that export
flagellin subunits actually stimulated slightly higher anti-FliC IgG
antibody titers (Fig. 5A–B). However, when we dissected the anti-
FliC response we found that while all three vaccine strains
induced IgG2a anti-FliC, the flagellin-secreting strains (CVD
1901D and 1901K) induced significantly higher IgG1 anti-FliC
titers (Fig. 6, p=0.012). IgG1 or IgG2a serum antibody responses
in mice imply induction of TH2- or TH1-type subsets,
respectively. Thus, both soluble and cell-attached polymeric FliC
evoke TH1-directed switching to IgG2a but the IgG1 response is
related to context. Whereas strong serum IgG1 anti-FliC
responses were elicited by soluble exported FliC, this protein
did not induce a strong IgG1-dependent TH2 response when
presented as a bacterial cell-attached polymer, as observed for
CVD 1901. Others have reported that mucosal administration of
purified S. Typhimurium flagellin elicits a strong TH2-type
response [51–53], while attached flagella on S. Typhimurium
induce predominantly a TH1-dependent response [53]. Thus, the
type of response against S. Typhimurium FliC did not seem to be
determined by any intrinsic properties of FliC but rather
appeared to be influenced by the form in which FliC was
encountered, either as a soluble or cell-associated antigen [53].
Both monomeric and polymeric FliC induced TH2 responses
provided these proteins were intact and not attached to cells, and
only FliC on cells induced mainly a TH1 response [53]. Similar
observations have been shown for Lactobacillus-associated and
soluble FliC [54], indicating a general mechanism for anti-FliC
antibody switching. We document the identical behavior for S.
Paratyphi A FliC protein. However, our study advances the field
since, in contrast to earlier reports, we presented FliC in vivo as
attached whole flagella or as FliC monomers exported by live
bacteria; previously, flagellin monomers or polymers were
administered as purified protein.
Figure 7. CVD 1901 cell-associated flagella elicits antibodies with opsonophagocytic rather than complement-mediated
bactericidal activity. (A) Serum-induced killing of ATCC 9150 (flagellated) and 9150K (non-flagellated) bacteria mediated by complement. Sera
are from day 42 of the experiment described in Fig. 5. (B) Opsonophagocytic activity of sera withdrawn at day 27 in J774A.1 macrophage against the
wild-type ATCC 9150 strain. For (A) and (B), closed shapes represent mice that succumbed to the challenge.
doi:10.1371/journal.pntd.0001373.g007
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FliC, we report an association between a specific IgG subtype and
protection. Vaccination with monomeric flagellin-exporting live
vaccines induced stronger IgG1 anti-FliC responses but less
protection against challenge with virulent S. Paratyphi A,
suggesting that a pronounced TH2 response does not predict
functional immunity.
One must ponder why certain specific antibodies elicited
following vaccination with whole organisms fail to protect. One
possibility is that some antibodies in excess may compete or block
specific phagocyte Fc receptors that endocytose or phagocytose
antibody-coated microorganisms [55]. Overwhelming Fc recep-
tors may interfere with clearance of the pathogen. An excess of
IgG1 anti-FliC antibodies induced by the exported FliC may
prevent binding of the IgG2a subtype anti-FliC that is critical for
clearing S. Paratyphi A infection. Alternatively, certain antibodies
that lack relevant biological activity may actually enhance rather
than control infection; thus, the high IgG1 anti-FliC may enhance
the uptake of bacteria into cells without triggering killing.
Antibodies that engage Fc receptors and enhance infection have
long been known for Chlamydia trachomatis [56].
The TH1 subset is responsible for cell-mediated functions such
as activation of cytotoxic T cells and production of opsonization-
promoting IgG antibodies that bind to high-affinity Fc receptors
and interact with the complement system. TH1 cells produce IL-2
and IFN-c that promote the differentiation of fully cytotoxic TC
cells, which are suited to respond to intracellular pathogens. IFN-c
is a defining cytokine of the TH1 subset and activates macrophages
to increase microbicidal activity [57]. IFN-c secretion by TH1 cells
also induces antibody class switching to IgG classes (IgG2a in the
mouse) that support phagocytosis and complement fixation.
Finally, in immunized mice most Salmonella-specific cells secreting
IFN-c are also FliC-specific [46].
Complement-dependent serum bactericidal antibodies [SBA]
are one functional serological response in humans exposed to
Salmonella pathogens or vaccines [58]. Our results show that SBA
did not correlate with protection (Fig. 7A). Replacing the
flagellated WT S. Paratyphi A ATCC 9150 utilized in the SBA
assay with non-flagellated strain 9150K, did not alter SBA titers,
indicating that anti-FliC antibodies did not function in this assay
or contributed only inconsequentially. SBA must bind antigenic
determinants on or very near the bacterial surface so that
complement may interact with lipid membrane components.
Thus, antibodies directed against flagella may be ineffective as
SBA.
By contrast, we found antibodies mediating opsonophagocytic
activity to be a useful functional correlate of protection against S.
Paratyphi A (Fig. 7B), as has also been proposed for invasive non-
typhoidal Salmonella infections [59]. A difference was observed in
the opsonophagocytic activity of sera collected from mice
immunized with CVD 1901 versus sera from mice immunized
with CVD 1901D or 1901K. Sera from CVD 1901 mice readily
mediated uptake of virulent S. Paratyphi A by phagocytes.
For every human vaccine for which a correlate of immunity
exists [60], the correlate is a serum antibody. Live Salmonella
vaccines elicit both cell-mediated and antibody responses and our
studies shed light on the role of immune responses to flagellar
protein elicited by a rationally-attenuated S. Paratyphi A live
vaccine. In addition, the unpolymerized FliC monomers produced
by our engineered strains could be exploited as subunit vaccines or
as a platform for engineered FliC-heterologous antigen fusions that
might not otherwise be supported within the confines of a
polymerized flagellum. An additional byproduct of our research is
the demonstration of a small animal model that allows, following
mucosal immunization, the efficacy of live S. Paratyphi A vaccines
to be assessed, including discernment among various candidates.
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